Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Greekman, couldn't agree more. Still on my watchlist though as will get there in the end. Put in perspective the time I have been watching this I have also bought GOO made 50% and sold taking the profit. Right now would be a great time for a hint of better times to come.....

I have just been to see the musical Jekyll and Hyde. It was fantastic and it gave me a lot of ideas. When I think of the nasty things Edward Hyde did to people, and then I think of those NHS management (sorry I mean manglement) who need a shock, I think maybe we could get Edward Hyde in to break a few necks and rip some intestines out...

Arf----Good idea, I bet they would insist on the Cardio Q being used during their ops.
2517

Up a tick so far this morning on small vol. and even that is in favour of the sellers, perhaps there is a buyer filling an order.
2517

NHS TO ADVERTISE,

According to the news the NHS is going to be allowed to advertise.
Just watched an advert for a hospital in the USA. It was slick and smooth.
Obviously as USA hospitals are run for profit, out there advertising has to be.
Whilst in general I think that in this country it will be a waste of our money, as if you need treatment and cant afford private, its the NHS or the NHS, I do feel competition, because that is what it will be, could be the push that makes hospital trust management get their heads out of the sand.
If one trust can show they can bring down recovery times and therefor overall hospital stay times it must surely bring more customers/patients to that trust.
Competition is a great motivator.
Lets hope these managers look to developments such as the CardioQ as a strong selling point.
No doubt the trusts will put their advertising out to the professionals, who I am sure will look at every selling angle there is.
No doubt statistics re operation, success rates, recovery times, quicker discharge times and lower re admissions, all documented by the CardioQ trials as better if CQ used will be publicized.
Although it has not yet been decided what these adverts will be allowed to contain, it has already been stated that the more patients treated, the bigger slice of the money pot they will receive.
Can any NHS trust risk lagging behind.

greeman the hospital news on advertising will help DEMG to sell their products to save time and money for the hospitals looking at their profit margins...

Peter our 79 year old called into our coffee meeting at shareclubuk this morning.. He was giving an update report on Deltex Medical.. He said that the company has first class products which would save a great deal of NHS funds. If only the Government would get of the backs of the hospital who would like to take up the disposable probes.. (sometimes you have to spend to save)

Peter went on to report the publication of a clinical trial which took place by Doctors at the Royal Free Hospital in London the trial took place as a randomised, controlled clinical trial comparing two approaches to epidural anaesthesia in women undergoing elective caesarean delivery

Peter said its out of the bag that Deltex Medicals SupraQ monitor came out on top.. Deltex has so much going for its products, thats its only a matter of time that the company must indeed make the break through sales wise in the medical world then the SP will move up at a rapid pace

Thing is its all been said time and time again before. Deltex has more selling points and excellent trial results than any other company in the medical industry that I know of, yet lacks sales. Lets just hope a cheaper alternative doesn't steal the market!!

Directors take shares.

Always good when directors take shares in lieu of a cash payment as remuneration for their services to the Company. It looks as if they have all taken to showing they have faith in the company.

Another good sign I agree Greekman, lets hope the contracts start to flow in reward of this remuneration for director and investor alike.

Morning Explosive,

Would be nice to see, but as all NHS Trusts are in the red can't see it happening this financial year, although we don't really know whats in the pipeline.
The Government stated (yesterday) that next year all the trusts will be out of debt.
And yet another pig flies past my window. They probably mean that as soon as the funding for the year is sorted, it clears the debt. Of course the funds have to last 12 further months so the debt spiral starts again.
Spin Spin and more Spin. Still we can only hope they see the light that the CardioQ can and does save money as well as lives.

It's the amount of directors taking the shares that pleases me.

Executive Directors
Andy Hill BSc MBA Chief Executive
Ewan Phillips MA ACA Finance Director

None Executives, with shares taken

Nigel Keen MA FCA Chairman 67,568
Dr Edwin Snape MSc PhD Vice-Chairman 48,649
Dr George Flouty MD 48,649
Peter Smedvig BA MBA 48,649
Professor Sir Duncan Nichol 37,946

So all the none execs offered the deal, took it.

Note that the offer was to the None Executives only.

In Total they hold 10,094,864 shares, 12.61% of the company.
To me that shows confidence.

Deltex will come good

Peter our 79 year old updated our morning coffee meeting at shareclubuk on Deltex Medical (DEMG) the company has seen growth in the use of it's disposable probe in the high volume operating market. The disposable probe is the main driver for the DEMG business..

On top of that the surgeon led trials on the use of DEMG's SupraQ monitor have all come out as positive time and time again.. the clinical trials data reports three day reduction in length of stay.. leading to cost saving for potential clients from the NHS, US and the European markets.. given time DEMG will come good...

Myway - Its all old news, nothing new I haven't read 18 months ago..... Your singing the same song from page 1 of this thread!! There progression for yer!... On a positive note Griffin up some 11p today triggers a sale.... DEMG however is yet to provide a reason to buy!

Yet again good news re reduced stays in hospital.

These are the reduced lenghts of stay as per RNS 19th. (for those who can't get a display re Moneyam, as at present unable to show yesterdays RNS for Deltex.)

Type of surgery Per patient bed day saving
Bowel resection 2.3 days
Gallbladder removal 1.6 days
Kidney removal 1.0 day
Bladder removal 7.5 days
Prostate surgery 1.2 to 2.1 days
Broken hip repair 7.8 days
Hip replacement 2.2 days
Spine surgery 1.5 days

Well thats it for me pre Xmas, off out.
Merry Xmas to all.
Greek.

Why no news indicator on Stockwatch....RNS Number:8679O Deltex Medical Group PLC 03 January 2007

And yet another positive study---------one day.
2517

My thoughts on why NHS Trusts are reluctant to go the way of Deltex and CardioQ.

It is excepted that the more patients an NHS Trust treats the more they go into debt.

The most costly time for patient care is usually the initial stages of care, IE operations followed by post op care. The costs diminish as discharge time is approached. The quicker you can discharge patients the more patients you can treat. As we often read or hear of surgeons being told to reduce the number of operations, and consultants being told to stretch their lists it appears that the best way to save money is to Bed Block. In other words keep patients in as long as possible, thus keeping those who require the initial expensive treatments out.
So save money.

I appreciate the above sounds ludicrous but that is what I heard as an explanation of how things are going via a comment made by a medical person yesterday.
The comment although appearing to be tongue in cheek, reeks of truth.
As we know with this government, all they care about is money not people (patients). The simple truth is several trusts have been told they are treating too many people. There is no incentive for hospitals to purchase a device that cuts down hospital stay times.

Its almost worthy of a Monty Python sketch.
As they say YOU COULDN'T MAKE IT UP.

Even more convinced, Deltex will make it big time but not in the UK.
If their patients were as sick as the NHS they would all be dead.

Good post Greekman, now this thread finally has some substance which is related to the market position. Its not about the savings or op time frames as we know, these have already been proven. Just one look at the NHS tells us that money is its primary concern right now. That position isn't however that of the market and Deltex should be pushing the private sector hard rather than winging about the NHS which isn't in the position to offer anything.

Sad but true, if the NHS was privitised then all Deltex holders would be laughing!!

If anyone saw the pro gramme last night re the NHS, (Can Gerry Robinson fix the NHS) it clearly showed when they visited the money holders (the trust finance mongers) that they did not want more patients treated as this would multiply the cost and put said trust even deeper in the red.
It also clearly showed what we all know, someone has a good idea, they then have a meeting (eventually), and then sit on any decision for months, sometimes years or as long as it takes to go away. No one is a decisive decision maker. The Exec was surprised to learn that if he got out among those that do the graft, ie on ground level they, the patients and he would benefit. Not exactly brain storming thinking, and this Exec must be very well paid. Gerry Robinson found out within a short period how to save money and time by talking to those who do the actual job from cleaners to consultants. Most of the suggestion were obviously. My wife who is a Nurse was continually commenting, " We have been saying this for years, and the management never listen". But this was a surprise to the Exec. Says it all really.